Significant Ownership of Qiming U.S. Healthcare Fund II, L.P.

Signature - Title
/s/ Mark McDade - By Qiming U.S. Healthcare GP II, LLC, its general partner, By Mark McDade, Managing Partner
Location
Bellevue, WA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Qiming U.S. Healthcare Fund II, L.P..

Notify me when Qiming U.S. Healthcare Fund II, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Qiming U.S. Healthcare Fund II, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JSPR Jasper Therapeutics, Inc. Voting Common Stock, par value $0.0001 3.3% $2,210,934 928,964 Qiming U.S. Healthcare Fund II, L.P. 30 Sep 2025

Schedules 13D/G Reported by Qiming U.S. Healthcare Fund II, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.